美国生物医药产业园区发展战略咨询报告(PDF 64).pdf

Massbiotech 2010
ACHEVNG GLOBAL LEADERSHP N
THE LIFE-SCENCES ECONOMY
THE BOSTON CONSULTING GROUP
MBG
Massachusetts Biotechnology Council
Copyright 2002, the Massachusetts Biotechnology Council, The Boston Consulting Group, All Rights Reserved
FOREWORD
Massachusetts can seize the opportunity to achieve global leadership in the life-sciences economy
The biotechnology industry will play a central role in enhancing human health while fueling
economic growth. Together we can be successful in continuing scientific excellence and creating
nearly 100,000 new jobs by 2010
Mass Biotech 2010: Achieving Globa/ Leadership in the Life-sciences Economy is the product of a three-month
study involving representatives from over 100 diverse groups including biotechnology companies
universities and academic medical centers, pharmaceutical companies; and federal, state and local
government leaders. The report articulates a vision for the Massachusetts biotechnology industr
and the broader life-sciences economic cluster. It identifies the main challenges and presents a
detailed call to action-for Massachusetts policymakers and for the life-sciences community
We thank the many individuals who gave their time, energy, and ideas to create a report with both
vision and depth. We acknowledge the significant contributions of the members of the MBC board,
many of whom served as leaders on the steering committee and on the nine topic teams; The Boston
Consulting Group for analytic rigor and professionalism in conducting research, coordinating inter
views, and writing the final report; and the leaders of major life-sciences organizations who provid-
ed their perspectives on biotechnology and its role in the Massachusetts life-sciences economy. All
individuals are listed by name in Appendix II of the report (starting on p. 59)
To achieve the vision by 2010, Massachusetts policymakers and biotech, academic, and medical lead
ers must work together. The Massachusetts Biotechnology Council is committed to the future of the
Commonwealths life-sciences economy and stands ready to make the vision a reality
nce
Bourque
Cynthia Fishe
President and CEO, Massachusetts Biotechnology Council
Chair, Massachusetts Biotechnology Council;
CEO, Biomed 20/20 Technologies, Inc
Joshua Boger
James Mull
Chairman and CEO. Vertex Pharmaceuticals, Inc
Chairman and CEO, Biogen, Inc
Garen Bohlin
Hans Nilsson
President and CEO, Syntonix Pharmaceuticals, Inc
Vice President, Site General Manager, Astrazeneca R&D Boston
L. Patrick G
Richard Pops
Consultant, Immediate Past President, Wyeth Research
CEO. Alkermes, Inc
lwn S. Ay.
Vaughn Kailian
na Rya
Vice Chairperson, Millennium Pharmaceuticals, Inc
President and CEO, Avant Immunotherapeutics, Inc
Mark Levin
Henri Termeer
CEO Millenium Pharmaceuticals Inc
Chairman, President, and CEO, Genzyme Corporation
A(2
David Mclachlan
Mark Trusheim
Senior Advisor, Genzyme Corporation
President and CEO. Cantata Pharmaceuticals, Inc